GLRX and cancer: Since cancer cells generally exhibit high ROS levels or exposure, the rewired metabolic network of PPP may enable cancer cells to counteract persistent oxidative stress by NADPH reduction, as NADPH is the direct or indirect donor of several reductive metabolites including thioredoxins, glutathione, glutaredoxins, peroxiredoxins, and glutathione peroxidases [38].